Hypoactive Sexual Desire Disorder (HSDD) Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: H9211812A7A8EN
Market Monitor Global

Abstracts

Hypoactive sexual desire disorder (HSDD) is the absence of sexual thoughts and fantasies causing low libido and sex drive in women population worldwide.

This report contains market size and forecasts of Hypoactive Sexual Desire Disorder (HSDD) Treatment in Global, including the following market information:

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hypoactive Sexual Desire Disorder (HSDD) Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Buspirone Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hypoactive Sexual Desire Disorder (HSDD) Treatment include AMAG Pharmaceuticals, Allergan, Plc., Ivix LLX, EndoCeutics, Inc., Emotional Brain BV, S1 Biopharma, Inc. and Sprout Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypoactive Sexual Desire Disorder (HSDD) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Segment Percentages, by Type, 2021 (%)

• Buspirone
• Bupropion
• Testosterone
• Flibanserin
• Bremelanotide
• Cognitive Behavior Therapy

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinic
• Others

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hypoactive Sexual Desire Disorder (HSDD) Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hypoactive Sexual Desire Disorder (HSDD) Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AMAG Pharmaceuticals
• Allergan, Plc.
• Ivix LLX
• EndoCeutics, Inc.
• Emotional Brain BV
• S1 Biopharma, Inc.
• Sprout Pharmaceuticals, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) TREATMENT OVERALL MARKET SIZE

2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size: 2021 VS 2028
2.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players in Global Market
3.2 Top Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies Ranked by Revenue
3.3 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Markets, 2021 & 2028
  4.1.2 Buspirone
  4.1.3 Bupropion
  4.1.4 Testosterone
  4.1.5 Flibanserin
  4.1.6 Bremelanotide
  4.1.7 Cognitive Behavior Therapy
4.2 By Type - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue & Forecasts
  4.2.1 By Type - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue & Forecasts
  5.2.1 By Application - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue & Forecasts
  6.2.1 By Region - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2017-2028
  6.3.2 US Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.3.3 Canada Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.3.4 Mexico Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2017-2028
  6.4.2 Germany Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.4.3 France Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.4.4 U.K. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.4.5 Italy Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.4.6 Russia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.4.8 Benelux Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2017-2028
  6.5.2 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.5.3 Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.5.4 South Korea Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.5.6 India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2017-2028
  6.6.2 Brazil Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.6.3 Argentina Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2017-2028
  6.7.2 Turkey Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.7.3 Israel Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028
  6.7.5 UAE Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AMAG Pharmaceuticals
  7.1.1 AMAG Pharmaceuticals Corporate Summary
  7.1.2 AMAG Pharmaceuticals Business Overview
  7.1.3 AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Major Product Offerings
  7.1.4 AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in Global Market (2017-2022)
  7.1.5 AMAG Pharmaceuticals Key News
7.2 Allergan, Plc.
  7.2.1 Allergan, Plc. Corporate Summary
  7.2.2 Allergan, Plc. Business Overview
  7.2.3 Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Major Product Offerings
  7.2.4 Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in Global Market (2017-2022)
  7.2.5 Allergan, Plc. Key News
7.3 Ivix LLX
  7.3.1 Ivix LLX Corporate Summary
  7.3.2 Ivix LLX Business Overview
  7.3.3 Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Major Product Offerings
  7.3.4 Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in Global Market (2017-2022)
  7.3.5 Ivix LLX Key News
7.4 EndoCeutics, Inc.
  7.4.1 EndoCeutics, Inc. Corporate Summary
  7.4.2 EndoCeutics, Inc. Business Overview
  7.4.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Major Product Offerings
  7.4.4 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in Global Market (2017-2022)
  7.4.5 EndoCeutics, Inc. Key News
7.5 Emotional Brain BV
  7.5.1 Emotional Brain BV Corporate Summary
  7.5.2 Emotional Brain BV Business Overview
  7.5.3 Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Major Product Offerings
  7.5.4 Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in Global Market (2017-2022)
  7.5.5 Emotional Brain BV Key News
7.6 S1 Biopharma, Inc.
  7.6.1 S1 Biopharma, Inc. Corporate Summary
  7.6.2 S1 Biopharma, Inc. Business Overview
  7.6.3 S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Major Product Offerings
  7.6.4 S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in Global Market (2017-2022)
  7.6.5 S1 Biopharma, Inc. Key News
7.7 Sprout Pharmaceuticals, Inc.
  7.7.1 Sprout Pharmaceuticals, Inc. Corporate Summary
  7.7.2 Sprout Pharmaceuticals, Inc. Business Overview
  7.7.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Major Product Offerings
  7.7.4 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in Global Market (2017-2022)
  7.7.5 Sprout Pharmaceuticals, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Opportunities & Trends in Global Market
Table 2. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers in Global Market
Table 3. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints in Global Market
Table 4. Key Players of Hypoactive Sexual Desire Disorder (HSDD) Treatment in Global Market
Table 5. Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Type
Table 9. List of Global Tier 1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AMAG Pharmaceuticals Corporate Summary
Table 31. AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Offerings
Table 32. AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Allergan, Plc. Corporate Summary
Table 34. Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Offerings
Table 35. Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Ivix LLX Corporate Summary
Table 37. Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Offerings
Table 38. Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (US$, Mn), (2017-2022)
Table 39. EndoCeutics, Inc. Corporate Summary
Table 40. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Offerings
Table 41. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Emotional Brain BV Corporate Summary
Table 43. Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Offerings
Table 44. Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (US$, Mn), (2017-2022)
Table 45. S1 Biopharma, Inc. Corporate Summary
Table 46. S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Offerings
Table 47. S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Sprout Pharmaceuticals, Inc. Corporate Summary
Table 49. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Offerings
Table 50. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Segment by Type in 2021
Figure 2. Hypoactive Sexual Desire Disorder (HSDD) Treatment Segment by Application in 2021
Figure 3. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2021
Figure 8. By Type - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share, 2017-2028
Figure 12. US Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share, 2017-2028
Figure 24. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)